Picture: Amarna Therapeutics

Amarna Therapeutics appointed new CEO

Dutch Amarna Therapeutics has appointed Dr Steen Klysner. The new CEO has been active in the bio­tech industry for more than 30 years

His predecessor Ben van Leent, Amarna founder and CEO, joined the company’s Supervisory Board. “Steen brings an extensive background as a biotech CEO to Swedish ExpreS2ion Biotech Holding AB & the Danisch ExpreS2ion Biotechnologies ApS, preceded by an impressive track record in execution and value creation within the biotech industry. His leadership experience makes Steen an ideal candidate to lead Amarna into its next stage of growth and development.”, said Thomas Eldered, Chairman of Amarnas’ Supervisory Board. Other stations from Klysner with different management roles were Allergo­pharma, Nordic Vaccine, and additional positions at Pharmexa, Novo Nordisk and ALK.